Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Villard

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|January 2, 2009
[Active drug monitoring of adverse drug reactions in pediatric emergency department]F Planchamp, K-A Nguyen, T Vial, et al.
Journal of Lipid Research|February 17, 2012
Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemiaAlexina Orsoni, Elise F Villard, Eric Bruckert, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|May 4, 2000
[Liver transplantation in infants and children. Evaluation of the first 40 cases (March 1991-March 1997)]A Lachaux, B Eid, D Stamm, et al.
Atherosclerosis|January 15, 2013
Endogenous CETP activity as a predictor of cardiovascular risk: determination of the optimal rangeElise F Villard, Marie-Christine Federspiel, Corinne Cherfils, et al.
Clinical Science (London, England : 1979)|January 22, 2017
The complexity of lipoprotein (a) lowering by PCSK9 monoclonal antibodiesGilles Lambert, Aurélie Thedrez, Mikaël Croyal, et al.
European Annals of Allergy and Clinical Immunology|July 10, 2009
Oral food challenge in children: an expert reviewF Rancé, A Deschildre, F Villard-Truc, et al.
Biomolecules|May 30, 2020
Reduced Reverse Cholesterol Transport Efficacy in Healthy Men with Undesirable Postprandial Triglyceride ResponseAlexandre Motte Motte, Julie Gall Gall, Joe-Elie Salem, et al.
Journal of Internal Medicine|January 17, 2014
Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathyR Szalat, J Pirault, J-P Fermand, et al.
JACC. Basic to Translational Science|January 9, 2018
PCSK9 Modulates the Secretion But Not the Cellular Uptake of Lipoprotein(a) Ex Vivo: An Effect Blunted by AlirocumabElise F Villard, Aurélie Thedrez, Jorg Blankenstein, et al.
JACC. Basic to Translational Science|July 3, 2020
Lipoprotein(a) Cellular Uptake Ex Vivo and Hepatic Capture In Vivo Is Insensitive to PCSK9 Inhibition With AlirocumabKévin Chemello, Sandra Beeské, Thi Thu Trang Tran, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|January 2, 2009
[Active drug monitoring of adverse drug reactions in pediatric emergency department]F Planchamp, K-A Nguyen, T Vial, et al.
Journal of Lipid Research|February 17, 2012
Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemiaAlexina Orsoni, Elise F Villard, Eric Bruckert, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|May 4, 2000
[Liver transplantation in infants and children. Evaluation of the first 40 cases (March 1991-March 1997)]A Lachaux, B Eid, D Stamm, et al.
Atherosclerosis|January 15, 2013
Endogenous CETP activity as a predictor of cardiovascular risk: determination of the optimal rangeElise F Villard, Marie-Christine Federspiel, Corinne Cherfils, et al.
Clinical Science (London, England : 1979)|January 22, 2017
The complexity of lipoprotein (a) lowering by PCSK9 monoclonal antibodiesGilles Lambert, Aurélie Thedrez, Mikaël Croyal, et al.
European Annals of Allergy and Clinical Immunology|July 10, 2009
Oral food challenge in children: an expert reviewF Rancé, A Deschildre, F Villard-Truc, et al.
Biomolecules|May 30, 2020
Reduced Reverse Cholesterol Transport Efficacy in Healthy Men with Undesirable Postprandial Triglyceride ResponseAlexandre Motte Motte, Julie Gall Gall, Joe-Elie Salem, et al.
Journal of Internal Medicine|January 17, 2014
Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathyR Szalat, J Pirault, J-P Fermand, et al.
JACC. Basic to Translational Science|January 9, 2018
PCSK9 Modulates the Secretion But Not the Cellular Uptake of Lipoprotein(a) Ex Vivo: An Effect Blunted by AlirocumabElise F Villard, Aurélie Thedrez, Jorg Blankenstein, et al.
JACC. Basic to Translational Science|July 3, 2020
Lipoprotein(a) Cellular Uptake Ex Vivo and Hepatic Capture In Vivo Is Insensitive to PCSK9 Inhibition With AlirocumabKévin Chemello, Sandra Beeské, Thi Thu Trang Tran, et al.
Pageof 4